Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Thakur

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ACS Omega|December 22, 2025
Inhibition Mechanism and Target Reassessment of Potent Piperaquine Analogs: Evidence for <i>Pf</i>LDH over <i>Pf</i>DHODHThejus Varghese Thomas, Amrita Thakur, S Anil Kumar, et al.
ACS Omega|January 1, 2026
RL-MSVP: Reinforcement Learning and Multi-scale Validation Pipeline Investigating Azole-Fused Pyrimidines as Potential <i>Pf</i>DHODH InhibitorsThejus Varghese Thomas, Amrita Thakur, Anil Kumar S, et al.
ACS Omega|March 9, 2026
EGFR Mutations and Tyrosine Kinase Inhibitors: Structural Insights and Therapeutic AdvancesMegha V Manoj, Ramesh Babu Mupparaju V, Amrita Thakur, et al.
Scientific Reports|June 29, 2026
ReLink-PyB: an adapted REINVENT-based framework for non-DSM PfDHODH inhibitor discoveryThejus Varghese Thomas, Amrita Thakur, S Anil Kumar, et al.
Chemical Biology & Drug Design|December 11, 2024
Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular AgentsNitin Govind Sonawane, Amrita Thakur, Anil Kumar Sasidharan Pillai, et al.
Molecular Diversity|November 5, 2025
Discovery of potent DprE1-targeted antitubercular agents: synthesis and evaluation of PBTZ169/TBA7371-based derivativesGunjal Amol Pandurang, S Anil Kumar, Amrita Thakur, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ACS Omega|December 22, 2025
Inhibition Mechanism and Target Reassessment of Potent Piperaquine Analogs: Evidence for <i>Pf</i>LDH over <i>Pf</i>DHODHThejus Varghese Thomas, Amrita Thakur, S Anil Kumar, et al.
ACS Omega|January 1, 2026
RL-MSVP: Reinforcement Learning and Multi-scale Validation Pipeline Investigating Azole-Fused Pyrimidines as Potential <i>Pf</i>DHODH InhibitorsThejus Varghese Thomas, Amrita Thakur, Anil Kumar S, et al.
ACS Omega|March 9, 2026
EGFR Mutations and Tyrosine Kinase Inhibitors: Structural Insights and Therapeutic AdvancesMegha V Manoj, Ramesh Babu Mupparaju V, Amrita Thakur, et al.
Scientific Reports|June 29, 2026
ReLink-PyB: an adapted REINVENT-based framework for non-DSM PfDHODH inhibitor discoveryThejus Varghese Thomas, Amrita Thakur, S Anil Kumar, et al.
Chemical Biology & Drug Design|December 11, 2024
Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular AgentsNitin Govind Sonawane, Amrita Thakur, Anil Kumar Sasidharan Pillai, et al.
Molecular Diversity|November 5, 2025
Discovery of potent DprE1-targeted antitubercular agents: synthesis and evaluation of PBTZ169/TBA7371-based derivativesGunjal Amol Pandurang, S Anil Kumar, Amrita Thakur, et al.
Pageof 1